These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 22539349)

  • 1. Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases.
    Becker GL; Lu Y; Hardes K; Strehlow B; Levesque C; Lindberg I; Sandvig K; Bakowsky U; Day R; Garten W; Steinmetzer T
    J Biol Chem; 2012 Jun; 287(26):21992-2003. PubMed ID: 22539349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent inhibitors of furin and furin-like proprotein convertases containing decarboxylated P1 arginine mimetics.
    Becker GL; Sielaff F; Than ME; Lindberg I; Routhier S; Day R; Lu Y; Garten W; Steinmetzer T
    J Med Chem; 2010 Feb; 53(3):1067-75. PubMed ID: 20038105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of the binding pockets of mammalian proprotein convertases and its implications for the design of specific small molecule inhibitors.
    Tian S; Jianhua W
    Int J Biol Sci; 2010 Feb; 6(1):89-95. PubMed ID: 20151049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Furin Inhibitors with Potent Anti-infectious Activity.
    Hardes K; Becker GL; Lu Y; Dahms SO; Köhler S; Beyer W; Sandvig K; Yamamoto H; Lindberg I; Walz L; von Messling V; Than ME; Garten W; Steinmetzer T
    ChemMedChem; 2015 Jul; 10(7):1218-31. PubMed ID: 25974265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elongated and Shortened Peptidomimetic Inhibitors of the Proprotein Convertase Furin.
    Hardes K; Ivanova T; Thaa B; McInerney GM; Klokk TI; Sandvig K; Künzel S; Lindberg I; Steinmetzer T
    ChemMedChem; 2017 Apr; 12(8):613-620. PubMed ID: 28334511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and characterization of novel fluorogenic substrates of the proprotein convertases furin, PC1/3, PC2, PC5/6, and PC7.
    Lam van TV; Ivanova T; Lindberg I; Böttcher-Friebertshäuser E; Steinmetzer T; Hardes K
    Anal Biochem; 2022 Oct; 655():114836. PubMed ID: 35964735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New substrate analogue furin inhibitors derived from 4-amidinobenzylamide.
    Becker GL; Hardes K; Steinmetzer T
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4695-7. PubMed ID: 21757345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of furin/proprotein convertase-catalyzed surface and intracellular processing by small molecules.
    Komiyama T; Coppola JM; Larsen MJ; van Dort ME; Ross BD; Day R; Rehemtulla A; Fuller RS
    J Biol Chem; 2009 Jun; 284(23):15729-38. PubMed ID: 19332539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histidine-rich human salivary peptides are inhibitors of proprotein convertases furin and PC7 but act as substrates for PC1.
    Basak A; Ernst B; Brewer D; Seidah NG; Munzer JS; Lazure C; Lajoie GA
    J Pept Res; 1997 Jun; 49(6):596-603. PubMed ID: 9266488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of furin inhibitors to protect against the activation of influenza hemagglutinin H5 and Shiga toxin.
    Gagnon H; Beauchemin S; Kwiatkowska A; Couture F; D'Anjou F; Levesque C; Dufour F; Desbiens AR; Vaillancourt R; Bernard S; Desjardins R; Malouin F; Dory YL; Day R
    J Med Chem; 2014 Jan; 57(1):29-41. PubMed ID: 24359257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of inhibitors of prohormone convertases 1 and 2 using a peptide combinatorial library.
    Apletalina E; Appel J; Lamango NS; Houghten RA; Lindberg I
    J Biol Chem; 1998 Oct; 273(41):26589-95. PubMed ID: 9756897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Structure and properties of proprotein convertase inhibitors].
    Kibirev VK; Osadchuk TV
    Ukr Biokhim Zh (1999); 2012; 84(2):5-29. PubMed ID: 22642118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis, and Characterization of Macrocyclic Inhibitors of the Proprotein Convertase Furin.
    Van Lam van T; Ivanova T; Hardes K; Heindl MR; Morty RE; Böttcher-Friebertshäuser E; Lindberg I; Than ME; Dahms SO; Steinmetzer T
    ChemMedChem; 2019 Mar; 14(6):673-685. PubMed ID: 30680958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate cleavage analysis of furin and related proprotein convertases. A comparative study.
    Remacle AG; Shiryaev SA; Oh ES; Cieplak P; Srinivasan A; Wei G; Liddington RC; Ratnikov BI; Parent A; Desjardins R; Day R; Smith JW; Lebl M; Strongin AY
    J Biol Chem; 2008 Jul; 283(30):20897-906. PubMed ID: 18505722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of prohepcidin processing and activity by the subtilisin-like proprotein convertases Furin, PC5, PACE4 and PC7.
    Scamuffa N; Basak A; Lalou C; Wargnier A; Marcinkiewicz J; Siegfried G; Chrétien M; Calvo F; Seidah NG; Khatib AM
    Gut; 2008 Nov; 57(11):1573-82. PubMed ID: 18664504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering of α1-antitrypsin variants with improved specificity for the proprotein convertase furin using site-directed random mutagenesis.
    Hada K; Isshiki K; Matsuda S; Yuasa K; Tsuji A
    Protein Eng Des Sel; 2013 Feb; 26(2):123-31. PubMed ID: 23155057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proprotein convertase models based on the crystal structures of furin and kexin: explanation of their specificity.
    Henrich S; Lindberg I; Bode W; Than ME
    J Mol Biol; 2005 Jan; 345(2):211-27. PubMed ID: 15571716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of Substrate-Analogue Furin Inhibitors.
    Ivanova T; Hardes K; Kallis S; Dahms SO; Than ME; Künzel S; Böttcher-Friebertshäuser E; Lindberg I; Jiao GS; Bartenschlager R; Steinmetzer T
    ChemMedChem; 2017 Dec; 12(23):1953-1968. PubMed ID: 29059503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short polybasic peptide sequences are potent inhibitors of PC5/6 and PC7: Use of positional scanning-synthetic peptide combinatorial libraries as a tool for the optimization of inhibitory sequences.
    Fugere M; Appel J; Houghten RA; Lindberg I; Day R
    Mol Pharmacol; 2007 Jan; 71(1):323-32. PubMed ID: 17012622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The family of subtilisin/kexin like pro-protein and pro-hormone convertases: divergent or shared functions.
    Seidah NG; Chrétien M; Day R
    Biochimie; 1994; 76(3-4):197-209. PubMed ID: 7819324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.